FDA Drug · D-0834-2026

traZODone Hydrochloride Tablets, USP, 50 mg, Rx only, 100 Tablets, Manufactured in Croatia By: Pliva Hrvatska d.o.o, Zagreb, Croatia, Manufactured For: Teva Pharmaceuticals, Parsippany, NJ 07054, NDC 50111-560-01

Class II · Ongoing

Presence of Foreign Tablets/Capsules

Affected lots / codes — check yours against thisLot: 1394026, Exp. 02/2028.

Recalling firm: Teva Pharmaceuticals USA, Inc, Parsippany, NJ
Classification: Class II (temporary or reversible harm possible)
Status: Ongoing
Quantity: 175,392 bottles
Distribution: U.S. Nationwide
Recall initiated: August 24, 2026
Classified: September 8, 2026
Initiation: Voluntary: Firm initiated

Official source. This record is published by the U.S. FDA through the openFDA enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0834-2026%22

Important. Recalls target specific lots and codes — compare the affected lots above against your own product. This page reproduces public FDA data for readability; EveryRecall is independent and not affiliated with the FDA.

Check this brand across all 8 databases →